title: [Recommendations for the use of rotavirus vaccines in industrialized countries].
abstract: Rotavirus (RV) infection is an important cause of morbidity all over the world. In industrialised countries the mortality is low, but the sanitary and social burden of the disease is important. Two safe and effective vaccines are available: Rotarix, live attenuated monovalent human derived vaccine, and RotaTeq, live attenuated pentavalent human-bovine reassortant vaccine. In USA, ACIP recently recommended anti RV vaccination to all children. In Europe both vaccines have been approved by EMEA. In Italy no official recommendation has been yet prepared.
authors.affiliation: Dipartimento Sanità Pubblica, Università di Roma Tor Vergata. franco@med.uniroma2.it
authors.forename: Elisabetta
authors.initials: E
authors.lastname: Franco
mesh_terms: D019049:Developed Countries; D005060:Europe; D006801:Humans; D017410:Practice Guidelines as Topic; D012400:Rotavirus Infections / Q000517:prevention & control* / Q000821:virology; D022243:Rotavirus Vaccines / Q000627:therapeutic use*; D014481:United States; D014613:Vaccines, Attenuated / Q000627:therapeutic use*
chemical_list: C492457:RIX4414 vaccine; C492535:RotaTeq; D022243:Rotavirus Vaccines; D014613:Vaccines, Attenuated